Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
AiVita Biomedical, Inc. See All Filings	D	2022-08-30 16:29:38 UTC
Amount To Be Raised $84,999,990 Associated Brokers / Dealers N/A CIK Number 0001676258 Filed Document 0001676258-22-000002 Exclusions or Exemptions 506b Accepted Date 2022-08-30 16:29:38 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets $$5,000,001 - $25,000,000 Type of Security Equity
AiVita Biomedical, Inc. See All Filings	D	2019-12-18 10:03:50 UTC
Amount To Be Raised $25,000,000 Associated Brokers / Dealers N/A CIK Number 0001676258 Filed Document 0001676258-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-12-18 10:03:50 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
AiVita Biomedical, Inc. See All Filings	D	2018-07-20 13:49:12 UTC
Amount To Be Raised $16,967,787 Associated Brokers / Dealers N/A CIK Number 0001676258 Filed Document 0001676258-18-000003 Exclusions or Exemptions 506b Accepted Date 2018-07-20 13:49:12 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
AiVita Biomedical, Inc. See All Filings	D/A	2018-03-15 14:19:49 UTC
Amount To Be Raised $5,499,233 Associated Brokers / Dealers N/A CIK Number 0001676258 Filed Document 0001676258-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-03-15 14:19:49 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
AiVita Biomedical, Inc. See All Filings	D	2016-06-06 13:09:19 UTC
Amount To Be Raised $3,007,670 Associated Brokers / Dealers N/A CIK Number 0001676258 Filed Document 0001676258-16-000001 Exclusions or Exemptions 506b Accepted Date 2016-06-06 13:09:19 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity